by Ben Beyer | Feb 10, 2020 | Blog
Start reaching out if you have not already to top targetsSpread a wide net. Extend your reach and target 20% or more new names. 2x outreach + personal emails. Master schedule, one pen. 30 min meetings; 15 min travel timeTry BIO’s 1×1 meeting platform or...
by Ben Beyer | Feb 9, 2020 | Blog
The EU’s signature framework for the financial markets is starting to have major impacts in the US What are the challenges and potential opportunities for companies in the life sciences? On January 3, 2018 the Market in Financial Instruments Directive (MiFID) II was...
by Ben Beyer | Feb 8, 2020 | Blog
LinkedIn is a critical tool for networking, branding, and showcasing the talent that makes your team unique. With a growing number of life science professionals on LinkedIn, your company’s presence on the platform can serve as a point of reference for investors,...
by Ben Beyer | Feb 7, 2020 | Blog
How you tell your company’s story before, during and after an IPO can have a big impact on your valuation and market success Preparing for an IPO signs you and your company up for months of hard strategizing, messaging and decision-making to effectively tap the...
by Ben Beyer | Feb 6, 2020 | Blog
With a crowd of social media platforms to master and so many digital marketing tools available, it’s not easy to determine which resources will work best for you and your company. As we discussed previously, social media is an important tool for life science...
by Ben Beyer | Feb 5, 2020 | Blog
Earlier this month, LaVoieHealthScience (LHS) announced the addition of Sharon Choe to our team. Sharon, who joined us from The Ruth Group in New York City, now serves as Senior Vice President, Investor Relations & Business Development with LHS. Sharon’s hiring...
Recent Comments